🇺🇸 FDA
Patent

US 6436929

Cyclothiocarbamate derivatives as progesterone receptor modulators

expired A61KA61K31/536A61K31/538

Quick answer

US patent 6436929 (Cyclothiocarbamate derivatives as progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
111
CPC classes
A61K, A61K31/536, A61K31/538, A61P, A61P15/00